%0 Journal Article
%T Monoaminergic impairment in Down syndrome with Alzheimer's disease compared to early-onset Alzheimer's disease
%A Alain D. Dekker
%A Alberto Lle¨®
%A Anne Sieben
%A Bessy Benejam
%A Debby Van Dam
%A Ellen Gelpi
%A Jean-Jacques Martin
%A Juan Fortea
%A Laura Videla
%A Maria Carmona-Iragui
%A Netherlands Brain Bank
%A Rafael Blesa
%A Sebastian Videla
%A Susana Fern¨˘ndez
%A Tony Aerts
%A Yannick Vermeiren
%J Archive of "Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring".
%D 2018
%R 10.1016/j.dadm.2017.11.001
%X People with Down syndrome (DS) are at high risk for Alzheimer's disease (AD). Defects in monoamine neurotransmitter systems are implicated in DS and AD but have not been comprehensively studied in DS
%K Alzheimer's disease
%K Cerebrospinal fluid
%K Dementia
%K Dopamine
%K Down syndrome
%K Monoamines
%K MHPG
%K Neurotransmitter
%K Noradrenaline
%K Plasma
%K Serotonin
%K Trisomy 21
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956808/